1.75
price up icon2.94%   0.05
after-market アフターアワーズ: 1.71 -0.04 -2.29%
loading
前日終値:
$1.70
開ける:
$1.7
24時間の取引高:
309.99K
Relative Volume:
0.72
時価総額:
$240.78M
収益:
-
当期純損益:
$-45.44M
株価収益率:
-4.7297
EPS:
-0.37
ネットキャッシュフロー:
$-42.28M
1週間 パフォーマンス:
+2.94%
1か月 パフォーマンス:
-9.33%
6か月 パフォーマンス:
+2.94%
1年 パフォーマンス:
-5.91%
1日の値動き範囲:
Value
$1.68
$1.795
1週間の範囲:
Value
$1.58
$1.83
52週間の値動き範囲:
Value
$0.765
$2.34

Compass Therapeutics Inc Stock (CMPX) Company Profile

Name
名前
Compass Therapeutics Inc
Name
セクター
Healthcare (1182)
Name
電話
617-500-8099
Name
住所
80 GUEST STREET, BOSTON
Name
職員
32
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
CMPX's Discussions on Twitter

Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-01-31 開始されました Jefferies Buy
2023-01-27 開始されました Stifel Buy
2022-05-23 再開されました H.C. Wainwright Buy
2022-03-15 開始されました Ladenburg Thalmann Buy
2022-01-19 開始されました B. Riley Securities Buy
2021-12-22 開始されました Raymond James Outperform
2021-12-20 開始されました SVB Leerink Outperform
2021-12-15 開始されました Wedbush Outperform
すべてを表示

Compass Therapeutics Inc (CMPX) 最新ニュース

pulisher
Nov 04, 2024

Treatment Resistant Depression Pipeline Therapeutics, - openPR

Nov 04, 2024
pulisher
Nov 01, 2024

Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace

Nov 01, 2024
pulisher
Oct 31, 2024

Compass delays anticipated psilocybin readout, cuts staff - Yahoo Finance

Oct 31, 2024
pulisher
Oct 27, 2024

Kidney Compass: Semaglutide for Nondiabetic Kidney Disease, with Hiddo Heerspink, PhD, PharmD, at Kidney Week 2024 - MD Magazine

Oct 27, 2024
pulisher
Oct 17, 2024

Compass Therapeutics, Inc. (NASDAQ:CMPX) Short Interest Update - MarketBeat

Oct 17, 2024
pulisher
Oct 16, 2024

Treatment Resistant Depression Clinical Trials 2024: FDA - openPR

Oct 16, 2024
pulisher
Oct 15, 2024

Cholangiocarcinoma Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - The Globe and Mail

Oct 15, 2024
pulisher
Oct 15, 2024

Can you now get a good deal on Compass Therapeutics Inc’s shares? - US Post News

Oct 15, 2024
pulisher
Oct 15, 2024

Financial Snapshot: Analyzing Compass Therapeutics Inc (CMPX)’s Key Ratio Metrics - The Dwinnex

Oct 15, 2024
pulisher
Oct 14, 2024

CMPX’s 2023 Market Dance: Up 26.92% – Time to Invest? - The InvestChronicle

Oct 14, 2024
pulisher
Oct 14, 2024

Renaissance Technologies LLC Decreases Position in Imperial Petroleum Inc. (NASDAQ:IMPP) - Defense World

Oct 14, 2024
pulisher
Oct 14, 2024

JetBlue Airways (NASDAQ:JBLU) Raised to “Sell” at StockNews.com - Defense World

Oct 14, 2024
pulisher
Oct 08, 2024

Cholangiocarcinoma Clinical Trials 2024: EMA, PDMA, FDA - openPR

Oct 08, 2024
pulisher
Oct 08, 2024

Silicon Laboratories Inc. (NASDAQ:SLAB) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Oct 08, 2024
pulisher
Oct 04, 2024

Compass Therapeutics Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting - ForexTV.com

Oct 04, 2024
pulisher
Oct 04, 2024

Compass Therapeutics Announces Upcoming Poster Presentation - GlobeNewswire

Oct 04, 2024
pulisher
Oct 03, 2024

Compass Therapeutics Inc (CMPX)’s stock price range in the last year - US Post News

Oct 03, 2024
pulisher
Oct 02, 2024

American Century Companies Inc. Cuts Stake in Compass Minerals International, Inc. (NYSE:CMP) - Defense World

Oct 02, 2024
pulisher
Sep 30, 2024

Compass Therapeutics, Inc. (NASDAQ:CMPX) Short Interest Up 23.7% in September - MarketBeat

Sep 30, 2024
pulisher
Sep 30, 2024

Rhumbline Advisers Takes Position in LINKBANCORP, Inc. (NASDAQ:LNKB) - Defense World

Sep 30, 2024
pulisher
Sep 30, 2024

Rhumbline Advisers Trims Holdings in Pembina Pipeline Co. (NYSE:PBA) - Defense World

Sep 30, 2024
pulisher
Sep 29, 2024

Analyzing Neurocrine Biosciences (NASDAQ:NBIX) and Compass Therapeutics (NASDAQ:CMPX) - Defense World

Sep 29, 2024
pulisher
Sep 27, 2024

NSK (OTCMKTS:NPSKY) Stock Price Passes Above 50-Day Moving Average of $10.02 - Defense World

Sep 27, 2024
pulisher
Sep 26, 2024

PCM Fund Inc. (NYSE:PCM) Short Interest Down 36.3% in September - Defense World

Sep 26, 2024
pulisher
Sep 26, 2024

Federated Hermes Inc. Has $51,000 Holdings in Deluxe Co. (NYSE:DLX) - Defense World

Sep 26, 2024
pulisher
Sep 26, 2024

Gencor Industries, Inc. (NASDAQ:GENC) Shares Acquired by Renaissance Technologies LLC - Defense World

Sep 26, 2024
pulisher
Sep 26, 2024

First Trust Cloud Computing ETF (NASDAQ:SKYY) Sets New 52-Week High at $103.17 - Defense World

Sep 26, 2024
pulisher
Sep 25, 2024

Biliary Tract Cancer Pipeline Analysis 2024: FDA Approvals - openPR

Sep 25, 2024
pulisher
Sep 25, 2024

Was anything positive for Compass Therapeutics Inc (CMPX) stock last session? - US Post News

Sep 25, 2024
pulisher
Sep 25, 2024

Compass Therapeutics Inc Inc. (CMPX) Price Performance: The Role of Supply and Demand - The InvestChronicle

Sep 25, 2024
pulisher
Sep 25, 2024

TSX Communication Services Capped Index (TTTS) QuotePress Release - The Globe and Mail

Sep 25, 2024
pulisher
Sep 23, 2024

Compass Diversified (NYSE:CODI) Insider Acquires $109,350.00 in Stock - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Balance Sheet Insights: Compass Therapeutics Inc (CMPX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Oppenheimer Asset Management Inc. Invests $195,000 in Compass Minerals International, Inc. (NYSE:CMP) - Defense World

Sep 23, 2024
pulisher
Sep 20, 2024

Invesco Plc (IVZ-N) QuotePress Release - The Globe and Mail

Sep 20, 2024
pulisher
Sep 19, 2024

Compass, Inc. (NYSE:COMP) Short Interest Down 6.0% in August - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Excalibur (Cayman) Ltd Svf Sells 7,500,000 Shares of Compass, Inc. (NYSE:COMP) Stock - Defense World

Sep 19, 2024
pulisher
Sep 18, 2024

A stock that deserves closer examination: Compass Therapeutics Inc (CMPX) - US Post News

Sep 18, 2024
pulisher
Sep 17, 2024

Ladenburg Thalmann Upgrades Compass Therapeutics (CMPX) - MSN

Sep 17, 2024
pulisher
Sep 17, 2024

Head-To-Head Analysis: Galera Therapeutics (NASDAQ:GRTX) & Galectin Therapeutics (NASDAQ:GALT) - Defense World

Sep 17, 2024
pulisher
Sep 16, 2024

Ladenburg raises Compass Therapeutics shares to Buy rating with no target change - Investing.com Canada

Sep 16, 2024
pulisher
Sep 16, 2024

Compass Therapeutics (NASDAQ:CMPX) Lifted to Buy at LADENBURG THALM/SH SH - MarketBeat

Sep 16, 2024
pulisher
Sep 13, 2024

Executive team - Compass Pathways

Sep 13, 2024
pulisher
Sep 08, 2024

National Bank of Canada FI Boosts Position in VICI Properties Inc. (NYSE:VICI) - Defense World

Sep 08, 2024
pulisher
Sep 06, 2024

Upward Trajectory: Compass Therapeutics Inc (CMPX) Posts a Slidee, Closing at 1.49 - The Dwinnex

Sep 06, 2024
pulisher
Sep 05, 2024

Enphase Energy, Inc. (NASDAQ:ENPH) Shares Sold by Panagora Asset Management Inc. - Defense World

Sep 05, 2024
pulisher
Sep 05, 2024

Panagora Asset Management Inc. Invests $323,000 in Ring Energy, Inc. (NYSEAMERICAN:REI) - Defense World

Sep 05, 2024
pulisher
Sep 05, 2024

Fox Co. (NASDAQ:FOXA) Shares Sold by Panagora Asset Management Inc. - Defense World

Sep 05, 2024
pulisher
Sep 05, 2024

Genworth Financial, Inc. (NYSE:GNW) Shares Bought by Zurcher Kantonalbank Zurich Cantonalbank - Defense World

Sep 05, 2024
pulisher
Sep 05, 2024

Tobam Has $3.27 Million Position in Meta Platforms, Inc. (NASDAQ:META) - Defense World

Sep 05, 2024
pulisher
Sep 05, 2024

Panagora Asset Management Inc. Lowers Stake in Quad/Graphics, Inc. (NYSE:QUAD) - Defense World

Sep 05, 2024

Compass Therapeutics Inc (CMPX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
大文字化:     |  ボリューム (24 時間):